Boosting capabilities through collaboration8 Oct 2017
CDMO, Micro-Sphere partners with German machine manufacturer Harro Höfliger for the latest step in its 21 million CHF (€19 million) investment into its facility in Switzerland.
Micro-Sphere, a CDMO specialising in the spray drying of APIs and HPAPIs, noticed a growing interest in using spray drying as a technology for particle engineering in the field of respiratory dry powders. Listening to respected and long-standing clients and keeping abreast of technological advances in the market, the CDMO decided to increase its capabilities, adding new technology to satisfy clients' new needs.
After consulting a number of experts and suppliers, and considering various options, Micro-Sphere concluded their next logical step was to source a technical partner to supply the best available technology to fill spray-dried powder in capsules ‒ the Harro Hofliger Modu-C MS unit.
This capsule filling machine boosts Micro-Sphere’s capsule filling production. A notional production of 72,000 capsules per hour and a 100% net weight check control, grant the correct dose when filling capsules for dry powder inhalers.
Micro-Sphere was satisfied that Harro Höfliger offered the best technology to handle cohesive spray-dried powders for respiratory applications and would be the right partner for the job.
Spray dried powders are sensitive and versatile in terms of physical characteristics and handling needs. The Modu-C Drum dosing technology has the capability to allow for careful powder feeding and precise metering without causing negative impact on final product performance (powder dispersion, stability, etc.) and is therefore the perfect solution for Micro-Sphere's needs.
Adding this capacity has given Micro-Sphere a powerful tool to cover client needs from clinical through to commercial launch.
Micro-Sphere founder and president of the Board, Dr Michele Müller, said: “Low-dose capsule filling is becoming increasingly popular across the market and at present we are the only CDMO in Europe offering this level of capability.
“Harro Höfliger’s powder expertise and technological competence is particularly evident in the Modu-C MS. This investment is an important next step in our expansion plans, allowing us to meet demand for greater capacity and speed up project delivery for our customers.”
Based in Allmersbach, Germany, Harro Höfliger develops and manufactures production and packaging systems and is a valued development partner for many pharmaceutical and medical technology companies.
Marco Laackmann, business unit leader, inhalation at Harro Höfliger added: “The capacitive fill quantity control of the Modu-C MS offers excellent process reliability and is a great choice for Micro-Sphere in line with its continued expansion. We’re delighted to be a part of their exciting future.”
Having been through the process of increasing capsule-filling capabilities, what has Micro-Sphere learnt and what advice can they offer companies in a similar situation?
First, the CDMO would encourage companies to consider collaborative working. "Besides the purchase of a piece of equipment, both companies are technology-driven and service orientated and this has created a positive, winning relationship for both the companies involved and our clients that can have their dry powder inhalers capsules quickly and properly filled under GMP."
It doesn't end with the delivery of the machinery either. Harro Höfliger offers continuous and competent postsale support, and as a result Micro-Sphere is learning how to get the best from the Modu-C-MS unit. Thanks to its clients and Micro-Sphere's spray drying expertise, Harro Höfliger is also learning more about challenges posed by cohesive spray-dried powders.
Micro-Sphere and Harro Höfliger teams are already working together side by side at Micro-Sphere's site to deliver more success stories.
Exciting skincare to protect against blue light emitted by phones and devices
10 Sep 2018
Novel, dual-acting product revitalizes and protects skin against blue light and environmental aggressors around the clock.Read more
Bio processing and manufacturing league table ranks US top and China bottom
3 Sep 2018
US, Germany and Japan revealed as tier one nations in all categories with Sweden ranking the best of the rest.Read more
Innovation "hindered by regulators"
27 Aug 2018
CPhI Annual Report expert sees CDMOs as potentially a source of process innovation but warns both regulator and license holders need to move past regulatory diktats.Read more
The 6-month FMD countdown - are you ready?
21 Aug 2018
With only 6 months left in which to become EU FMD-compliant, how can companies make the best use of their now limited options?Read more
Protecting the links between the UK and the EMA
14 Aug 2018
Now less than a year away from when the UK officially leaves the EU, the main goal remains the same - maintaining access to new drugs for patient health.Read more
Building contingency plans for an ambiguous post-Brexit market
31 Jul 2018
One company's positive approach to Brexit preparations, despite the lack of definition.Read more
Post-Brexit medicines - stuck in the UK?
30 Jul 2018
The EMA needs to provide more action and guidance to help UK pharmaceutical manufacturers, says Thomas Beck, senior vice president, quality management, Recipharm.Read more
Pharmacovigilance post-Brexit - simpler than previously thought?
24 Jul 2018
To meet new PV regulations, the industry has to face a "multitude of unknowns and an ever-moving target".Read more
South Korea's finished drug market growth driven by generics
16 Jul 2018
FDF launches at CPhI Korea as country set to become regional hub.Read more
Bosch to sell its packaging business
4 Jul 2018
Packaging technology is not a core Bosch business.Read more
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation